Ophthalmology Times - Ophthalmology news, articles, and events
WEBOphthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Physicians sort out pros and cons of several new IOLs on the market
WEBNov 12, 2021 · Monofocal IOLs The monofocal category was expanded recently with 2 novel aspheric hydrophobic acrylic lenses—the TECNIS Eyhance (ICB00, Johnson + Johnson Vision) and the Clareon (Alcon). The Eyhance IOL has extended depth of focus (EDoF)-like qualities through the design of the central 1 mm of its optic. However, the Eyhance was not approved as an EDoF lens and surgeons cannot charge a ...
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
WEBAug 8, 2023 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion.
FDA approves twice-daily dosing option for presbyopia eye drop …
WEBMar 30, 2023 · The FDA has approved a twice-daily dosing option of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults.. A second dose (one additional drop in each eye) may be administered 3 to 6 hours after the first dose.
Reaching consensus on Geographic Atrophy diagnosis and …
WEBMar 4, 2024 · Amid a continuing focus on stopping the progression to geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD), physicians and researchers are now fine-tuning the identification of the various disease stages, management scenarios, and treatment considerations for this patient population.. Carl D. Regillo, MD, from Mid Atlantic Retina as well as Wills Eye Hospital ...
Study suggests potential link between semaglutide and risk of non ...
WEBJul 9, 2024 · Boston researchers led by first author Jimena Tatiana Hathaway, MD, MPH, reported that there is a potential risk of the development of non-arteritic ischemic optic neuropathy (NAION) 1 associated with prescriptions for semaglutide (Wegovy, Ozempic, Novo Nordisk). Prescriptions with semaglutide are FDA approved to treat obesity and type 2 diabetes, respectively.
FDA approves eye drops for treatment of presbyopia
WEBOct 30, 2021 · Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults.
Myths and misconceptions about autologous serum for dry eye
WEBJun 22, 2020 · Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more convenient for patients and physicians alike.
FDA approves pilocarpine hydrochloride ophthalmic solution for ...
WEBOct 18, 2023 · Orasis Pharmaceuticals announces approval of Qlosi, a preservative-free, low-dose eye drop for presbyopia, which consistently demonstrated efficacy, safety, and tolerability in two pivotal Phase 3 trials.
Surgery | Ophthalmology News & Insights | Ophthalmology Times
WEBA team of 14 eyecare professionals made the recent trip including faculty from the Loyola Medicine Department of Ophthalmology and faculty and residents from Cook County Health, Northwestern Medicine, Wills Eye Hospital in Philadelphia, the University of Toledo College of Medicine and Champlain Ophthalmology in Bethesda, Maryland.